CD38 and Miyoshi myopathy: The mechanism of CD38 monoclonal antibodies (mAbs) treatment of MM is similar, such as complement-dependent cytotoxicity (CDC), antibody-dependent cell-mediated cytotoxicity (ADCC), and antibody-dependent cell-mediated phagocytosis (ADCP).